Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

jenscare.com

Founded Year

2011

Stage

Series B | Alive

Total Raised

$9.42M

About Jenscare Biotechnology

Jenscare Biotechnology focuses on R&D, production, sales, and services of minimally invasive interventional treatment of valves, and strives to provide solutions for doctors and patients.

Jenscare Biotechnology Headquarters Location

Ningbo, Zhejiang ,

China

+86 0574-63935666

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Jenscare Biotechnology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jenscare Biotechnology is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

8,493 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

7,901 items

  • When was Jenscare Biotechnology founded?

    Jenscare Biotechnology was founded in 2011.

  • Where is Jenscare Biotechnology's headquarters?

    Jenscare Biotechnology's headquarters is located at Ningbo.

  • What is Jenscare Biotechnology's latest funding round?

    Jenscare Biotechnology's latest funding round is Series B.

  • How much did Jenscare Biotechnology raise?

    Jenscare Biotechnology raised a total of $9.42M.

  • Who are the investors of Jenscare Biotechnology?

    Investors of Jenscare Biotechnology include Primavera Capital Group, Hillhouse Capital Management, Proxima Ventures, CDBI Partners, Shidi Investment and 11 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.